The timing of fatigue onset relative to medication initiation provides important diagnostic information, though coincidental conditions may emerge during treatment
While the mechanisms responsible for these potent effects remain incompletely understood, contributors include altered postprandial nutrient delivery to the intestine, increased secretion of glucagon-like peptide 1 (GLP-1) by intestinal L cells, increased insulin secretion, intestinal mucosal adaptations, alterations in the gut-brain axis, and changes in bile acid content and composition (3, 4)
Rapid weight loss reduces alcohol tolerance
Deepest pipeline: Eli Lilly leads in pipeline breadth and modality diversification approved assets across three distinct MoA classes (GLP-1R mono, GLP-1R/GIPR dual, oral SM, triple agonist in Phase 3)
Novo Nordisk Missed a dose of Ozempic (semaglutide)